• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prostate cancer nomograms and their application in Asian men: a review.前列腺癌列线图及其在亚洲男性中的应用:综述
Prostate Int. 2024 Mar;12(1):1-9. doi: 10.1016/j.prnil.2023.07.004. Epub 2023 Aug 4.
2
Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation.评估列线图对预测高危前列腺癌患者根治性前列腺切除术中标本局限性疾病的临床益处:一项外部验证。
Urol Oncol. 2015 Sep;33(9):384.e1-8. doi: 10.1016/j.urolonc.2015.02.017. Epub 2015 Jun 27.
3
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.预测前列腺癌根治术后生化复发男性前列腺癌特异性死亡率的列线图
Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.
4
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.两项术前列线图在一组欧洲男性中预测根治性前列腺切除术后复发情况的验证
Urol Oncol. 2002 Jul-Aug;7(4):141-6. doi: 10.1016/s1078-1439(02)00177-1.
5
Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.根治性前列腺切除术和放疗后生化复发结局是否相似?基于列线图预测生化复发风险的前列腺癌特异性死亡率分析。
Eur Urol. 2015 Feb;67(2):204-9. doi: 10.1016/j.eururo.2014.09.017. Epub 2014 Oct 5.
6
External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.术前列线图预测根治性前列腺切除术后生化复发的外部验证。
Jpn J Clin Oncol. 2013 Dec;43(12):1255-60. doi: 10.1093/jjco/hyt154. Epub 2013 Oct 21.
7
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.澳大利亚前列腺癌患者三种风险评估工具的比较分析。
BJU Int. 2011 Nov;108 Suppl 2:51-6. doi: 10.1111/j.1464-410X.2011.10687.x.
8
Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer.用于预测韩国临床局限性前列腺癌男性无复发生存概率的术前和术后列线图。
PLoS One. 2014 Jun 17;9(6):e100053. doi: 10.1371/journal.pone.0100053. eCollection 2014.
9
Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity.根治性前列腺切除术治疗前列腺癌患者临床结局预测的最优工具:预后准确性和有效性的系统评价。
Clin Genitourin Cancer. 2017 Oct;15(5):e827-e834. doi: 10.1016/j.clgc.2017.06.001. Epub 2017 Jun 8.
10
Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.综合多种临床特征预测前列腺癌患者行系统穿刺活检和根治性前列腺切除术时分级和分期的差异。
Pathol Res Pract. 2020 Nov;216(11):153235. doi: 10.1016/j.prp.2020.153235. Epub 2020 Oct 1.

引用本文的文献

1
Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms?亚洲前列腺癌盆腔淋巴结受累的真实世界患病率:我们是否需要重新思考正常图表?
Front Oncol. 2025 May 27;15:1583806. doi: 10.3389/fonc.2025.1583806. eCollection 2025.
2
Arthritis increases the risk of prostate cancer: Results from the National Health and Nutrition Examination Survey 2005-2018 and two-sample Mendelian randomization analysis.关节炎会增加患前列腺癌的风险:来自2005 - 2018年美国国家健康与营养检查调查以及两样本孟德尔随机化分析的结果。
Investig Clin Urol. 2025 May;66(3):215-226. doi: 10.4111/icu.20240313.
3
A new online dynamic nomogram based on the inflammation burden index to predict cardiac injury after antitumor therapy in lung cancer patients.一种基于炎症负荷指数的新型在线动态列线图,用于预测肺癌患者抗肿瘤治疗后的心脏损伤。
Cardiooncology. 2025 Mar 29;11(1):32. doi: 10.1186/s40959-025-00328-3.
4
Harnessing machine learning to predict prostate cancer survival: a review.利用机器学习预测前列腺癌生存率:综述
Front Oncol. 2025 Jan 10;14:1502629. doi: 10.3389/fonc.2024.1502629. eCollection 2024.
5
A prognostic nomogram of non-small cell lung cancer based on tumor marker inflammatory nutrition score.基于肿瘤标志物炎症营养评分的非小细胞肺癌预后列线图
Transl Lung Cancer Res. 2024 Dec 31;13(12):3392-3406. doi: 10.21037/tlcr-24-708. Epub 2024 Dec 26.
6
Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy.血精症不会增加前列腺活检中检测出前列腺癌的风险。
Prostate Int. 2024 Sep;12(3):151-154. doi: 10.1016/j.prnil.2024.06.004. Epub 2024 Jun 14.
7
Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer.前列腺癌根治术中扩大盆腔淋巴结清扫术的现状及治疗价值
Prostate Int. 2024 Sep;12(3):117-127. doi: 10.1016/j.prnil.2024.03.002. Epub 2024 Mar 17.
8
The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis.肥胖和性行为对前列腺癌风险的影响由睾酮水平介导:一项孟德尔随机化研究与中介分析
Prostate Int. 2024 Jun;12(2):96-103. doi: 10.1016/j.prnil.2024.03.003. Epub 2024 Mar 26.
9
Prognosis after radical prostatectomy in men older than 75 years: long-term results from a single tertiary center.75岁以上男性根治性前列腺切除术后的预后:来自单一三级中心的长期结果。
Prostate Int. 2024 Mar;12(1):15-19. doi: 10.1016/j.prnil.2023.09.004. Epub 2023 Sep 28.
10
A Novel Nomogram for Identifying the Patients at Risk for Rapid Progression of Advanced Hormone-Sensitive Prostate Cancer.一种用于识别晚期激素敏感性前列腺癌快速进展风险患者的新型列线图。
Cancer Manag Res. 2023 Sep 18;15:1015-1024. doi: 10.2147/CMAR.S425181. eCollection 2023.

本文引用的文献

1
Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels.前列腺特异性抗原动力学有助于活检转诊的决策制定:对 PSA 水平升高患者进行 PSA 复查的预测意义。
Prostate Int. 2023 Mar;11(1):27-33. doi: 10.1016/j.prnil.2022.08.001. Epub 2022 Aug 24.
2
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy.预测根治性前列腺切除术后无生化复发生存的新型列线图。
World J Urol. 2023 Jan;41(1):43-50. doi: 10.1007/s00345-022-04245-3. Epub 2022 Dec 17.
3
Development and internal validation of preoperative and postoperative nomograms predicting quadrifecta outcomes following robotic radical prostatectomy.预测机器人根治性前列腺切除术后四重奏结果的术前和术后列线图的开发与内部验证
Indian J Urol. 2022 Jul-Sep;38(3):197-203. doi: 10.4103/iju.iju_381_21. Epub 2022 Jul 1.
4
Prostate diseases and microbiome in the prostate, gut, and urine.前列腺疾病以及前列腺、肠道和尿液中的微生物群。
Prostate Int. 2022 Jun;10(2):96-107. doi: 10.1016/j.prnil.2022.03.004. Epub 2022 Mar 29.
5
Raised prostate-specific antigen alone may not be a true predictor in high-risk prostate cancer: A retrospective cohort analysis.单纯前列腺特异性抗原升高可能并非高危前列腺癌的真正预测指标:一项回顾性队列分析。
Indian J Urol. 2022 Jan-Mar;38(1):22-28. doi: 10.4103/iju.iju_368_21. Epub 2022 Jan 1.
6
Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview.前列腺癌特征及癌症特异性死亡率的种族差异:概述
World J Mens Health. 2022 Apr;40(2):217-227. doi: 10.5534/wjmh.210070. Epub 2022 Jan 1.
7
Development of an Indian nomogram for predicting extracapsular extension in prostate cancer.用于预测前列腺癌包膜外侵犯的印度列线图的开发。
Indian J Urol. 2021 Jan-Mar;37(1):65-71. doi: 10.4103/iju.IJU_200_20. Epub 2021 Jan 1.
8
Global Trends of Latent Prostate Cancer in Autopsy Studies.尸检研究中潜伏性前列腺癌的全球趋势
Cancers (Basel). 2021 Jan 19;13(2):359. doi: 10.3390/cancers13020359.
9
Asian Race and Risk of Prostate Cancer: Results from the REDUCE Study.亚洲种族与前列腺癌风险:REDUCE研究结果
Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2165-2170. doi: 10.1158/1055-9965.EPI-20-0646. Epub 2020 Aug 20.
10
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.近期全球前列腺癌发病率和死亡率模式。
Eur Urol. 2020 Jan;77(1):38-52. doi: 10.1016/j.eururo.2019.08.005. Epub 2019 Sep 5.

前列腺癌列线图及其在亚洲男性中的应用:综述

Prostate cancer nomograms and their application in Asian men: a review.

作者信息

Panaiyadiyan Sridhar, Kumar Rajeev

机构信息

Department of Urology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Prostate Int. 2024 Mar;12(1):1-9. doi: 10.1016/j.prnil.2023.07.004. Epub 2023 Aug 4.

DOI:10.1016/j.prnil.2023.07.004
PMID:38523898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10960090/
Abstract

Nomograms help to predict outcomes in individual patients rather than whole populations and are an important part of evaluation and treatment decision making. Various nomograms have been developed in malignancies to predict and prognosticate clinical outcomes such as severity of disease, overall survival, and recurrence-free survival. In prostate cancer, nomograms were developed for determining need for biopsy, disease course, need for adjuvant therapy, and outcomes. Most of these predictive nomograms were based on Caucasian populations. Prostate cancer is significantly affected by race, and Asian men have a significantly different racial and genetic susceptibility compared to Caucasians, raising the concern in generalizability of these nomograms. We reviewed the existing literature for nomograms in prostate cancer and their application in Asian men. There are very few studies that have evaluated the applicability and validity of the existing nomograms in these men. Most have found significant differences in the performance in this population. Thus, more studies evaluating the existing nomograms in Asian men or suggesting modifications for this population are required.

摘要

列线图有助于预测个体患者而非整个人群的预后,是评估和治疗决策的重要组成部分。在恶性肿瘤领域已开发出各种列线图,用于预测和推断疾病严重程度、总生存期和无复发生存期等临床结局。在前列腺癌中,列线图用于确定活检需求、疾病进程、辅助治疗需求及预后。这些预测性列线图大多基于白种人群。前列腺癌受种族影响显著,与白种人相比,亚洲男性具有明显不同的种族和遗传易感性,这引发了对这些列线图可推广性的担忧。我们回顾了关于前列腺癌列线图及其在亚洲男性中的应用的现有文献。很少有研究评估现有列线图在这些男性中的适用性和有效性。大多数研究发现该人群中的表现存在显著差异。因此,需要更多研究来评估现有列线图在亚洲男性中的情况,或针对该人群提出修改建议。